Rachel Slottke

Statistics

Publications

Citations

1.1K

H-Index

Active since

2009

Affiliations

Oregon Health & Science University(Current)

VA Portland Health Care System

Johns Hopkins University

Providence Portland Medical Center

Duke University

Rachel Slottke is an author at Oregon Health & Science University specializing in prostate cancer, metastatic castration-resistant prostate cancer, and medicine.

Publications per year

2009–2022

Publications

Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer

Julie N. Graff, Joshi J. Alumkal, Charles G. Drake et al. · Oncotarget · 2016 · 360 citations · Full text

Medicine, Oncology, Pharmacology +8

A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer

Joshi J. Alumkal, Rachel Slottke, Jacob Schwartzman et al. · Investigational New Drugs · 2014 · 222 citations · Full text

Medicine, Pharmacology, Urology +9

A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone

Julie N. Graff, Tomasz M. Beer, Joshi J. Alumkal et al. · Journal for ImmunoTherapy of Cancer · 2020 · 120 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer

Andrew J. Armstrong, Susan Halabi, Patrick Healy et al. · European Journal of Cancer · 2017 · 94 citations · Full text

Medicine, Oncology, Pharmacology +16

Gene expression profiling of whole blood: Comparison of target preparation methods for accurate and reproducible microarray analysis

Kristina Vartanian, Rachel Slottke, Timothy G. Johnstone et al. · BMC Genomics · 2009 · 87 citations · Full text

Life Sciences, Molecular Biology, Gene Expression +13

1–5 of 10